Gene: MTM1
Official Full Name: myotubularin 1provided by HGNC
Gene Summary: This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07887 | MTM1 Knockout cell line (HeLa) | Human | MTM1 | 1:3~1:6 | Negative | Online Inquiry |
KO07888 | MTM1 Knockout cell line (HCT 116) | Human | MTM1 | 1:2~1:4 | Negative | Online Inquiry |
KO07889 | MTM1 Knockout cell line (HEK293) | Human | MTM1 | 1:3~1:6 | Negative | Online Inquiry |
KO07890 | MTM1 Knockout cell line (A549) | Human | MTM1 | 1:3~1:4 | Negative | Online Inquiry |
MTM1 Gene Knockout Cell Lines are a specialized biological tool developed to facilitate the study of the myotubularin 1 (MTM1) gene, which is critically implicated in X-linked myotubular myopathy, a severe neuromuscular disorder. These cell lines are created using advanced gene-editing technologies, such as CRISPR-Cas9 or homologous recombination, to effectively disrupt the MTM1 gene, leading to a loss of function. By providing a cellular model that mimics the genetic alterations associated with MTM1 mutations, researchers can investigate the underlying molecular mechanisms contributing to this condition.
The primary function of MTM1 Gene Knockout Cell Lines is to enable the detailed examination of cellular pathways affected by MTM1 deficiency. As myotubularin proteins play significant roles in phosphoinositide metabolism and vesicular trafficking, these knockout lines allow scientists to study downstream effects on cellular processes such as muscle fiber development and myogenesis. Consequently, they serve as exemplary models for screening potential therapeutic interventions, elucidating disease pathophysiology, and understanding gene function in a controlled laboratory setting.
In terms of scientific importance, these cell lines are invaluable for translational research and drug discovery related to neuromuscular diseases. They permit the exploration of gene therapy approaches, small molecule screening, and the evaluation of novel therapeutic strategies aimed at mitigating the effects of MTM1 loss. Compared to alternative models, such as animal models or non-targeted cell lines, MTM1 Gene Knockout Cell Lines offer a precise, controllable environment that enhances the accuracy of experimental outcomes.
For researchers and clinicians focused on neuromuscular disorders, the availability of robust MTM1 Gene Knockout Cell Lines is essential. They not only contribute to the understanding of disease mechanisms but also accelerate the path towards effective therapies. Our company specializes in advanced biological products, bringing expertise in cell line development and gene editing to support your research needs. By choosing our MTM1 Gene Knockout Cell Lines, you are investing in a reliable tool that enhances the potential for groundbreaking discoveries in the field of genetics and regenerative medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.